A novel channelopathy in pulmonary arterial hypertension.
about
Pulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesisNeuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and PitfallsComplex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencingThe genetics of pulmonary arterial hypertensionMolecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionPulmonary arterial hypertension associated with congenital heart disease and Eisenmenger syndrome: current practice in pediatricsWhole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertensionIdentification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.Pancreatic β-cell-specific ablation of TASK-1 channels augments glucose-stimulated calcium entry and insulin secretion, improving glucose tolerance.Pulmonary arterial hypertension: the clinical syndrome.Pediatric pulmonary arterial hypertension.Sex differences in the pulmonary circulation: implications for pulmonary hypertensionUpdate in pulmonary vascular diseases 2013.Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USAFuture breakthroughs in the genetics of pulmonary arterial hypertension.Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associationsFunctional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension.Heritable forms of pulmonary arterial hypertension.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Genetics of pulmonary hypertensionGain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder.Progress in the diagnosis and management of pulmonary hypertension in children.Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.Implications of population structure and ancestry on asthma genetic studies.Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollutionMolecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.Building the case for novel clinical trials in pulmonary arterial hypertensionPeripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.Rescuing the BMPR2 signaling axis in pulmonary arterial hypertensionTwo-pore domain potassium channels in the adrenal cortex.Current clinical management of pulmonary arterial hypertensionMutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary HypertensionAccurate genetic diagnosis of Finnish pulmonary arterial hypertension patients using oligonucleotide-selective sequencing.Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries.A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.
P2860
Q26795562-FF36F993-78AF-4752-AC10-6EA3625A8C2BQ26798018-0761597D-4601-4CE3-9B80-06576B59FC41Q26864326-C0DD720A-D790-4974-9473-5022955C61E0Q27027507-1A9E560E-401A-4046-A8B3-3B82823898B5Q28067063-A8235C7A-FD18-48B5-8603-5680B949348EQ28085572-80B19389-90A3-4AC0-8551-E05C0B343E84Q28237461-5672FA70-DF96-47F0-A827-D34904ABA3B6Q28397539-145376A7-8B17-4E72-B9C8-C37120506FADQ30370626-52050E45-8DF0-4DC8-910A-8EDB0175427CQ30583630-7E8F74B1-6995-4A47-A553-A38BF0F3AF2BQ33163446-D8745B05-AA5A-423A-8B06-6210A17FF92FQ33568826-8D81D00A-A60F-4435-87CE-FBD8740FF2E0Q33732209-9A0B6633-CB8F-4136-9A5D-EF6F6339EBA7Q33739535-4430E544-0BE6-4FA9-88B0-7A50AC72C4ACQ33788468-F78B81BE-B07D-42EC-A944-CB01C4F96880Q33806126-BF2F28D4-5253-49CB-99DB-B363361FCF00Q33858783-D771149D-8A90-4969-8FC3-3EAEE3B1EA8AQ33901696-E0EC4CDE-EAB6-4278-993D-013E0BEFE5F9Q33915567-2A6850A7-8B4B-45D6-91E7-1D4A1B2FA5C2Q33965854-9FE05D8C-7FD4-4343-AC0C-F0A2A14861EAQ33991477-DA2B672C-94F1-4A1C-BD3D-F55867DAFA05Q34479289-3D9BC823-9645-4FDB-BE51-52A736AB05C1Q34495057-81F1941C-6D1D-4706-BD91-B7D247235F8DQ34781489-11E3A93B-8F5F-4F6D-958B-5FA7E595715BQ34782588-2574EE33-EBA4-4690-9F2C-485A8C02CA8BQ34800154-46D809C9-7396-45B4-8EB6-5C94D24B6B3BQ35005853-8CE7FF23-CC31-4FDF-809D-806A005B4599Q35019516-E890FBC1-6BB8-4B10-BF17-BE4A6AD0F014Q35115789-81288595-1BC3-4712-8C52-DEA159CD46FDQ35140747-0E6BA549-7095-496B-B8F0-36B38D1FE4B6Q35410950-D78B219E-DE25-4CE5-9B6F-4FE39C964068Q35597757-3EF3B908-9F02-4342-B0F7-55F77AF69033Q35673783-97958C88-22E9-449A-A453-73A30B84E1ADQ35689320-49C16EF9-6832-4A21-B535-DDF8CDDA0B0CQ35907239-CFFDCE70-0C0A-492E-9FC0-B34BBCF7D723Q35907757-FEFEA297-BD63-4EB3-9E8B-4F385A0044EDQ36016478-28295E4D-2C33-448C-A1E6-7884FB6B1DEDQ36186112-B9850D26-6E33-4BBF-A51F-CD06AFE107A6Q36310811-DF88343B-D771-4D90-A938-8D51B27A292EQ36340262-B9B67CAC-0B8C-4CAE-ACAB-2210EDB36E79
P2860
A novel channelopathy in pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel channelopathy in pulmonary arterial hypertension.
@en
A novel channelopathy in pulmonary arterial hypertension.
@nl
type
label
A novel channelopathy in pulmonary arterial hypertension.
@en
A novel channelopathy in pulmonary arterial hypertension.
@nl
prefLabel
A novel channelopathy in pulmonary arterial hypertension.
@en
A novel channelopathy in pulmonary arterial hypertension.
@nl
P2093
P2860
P50
P356
P1476
A novel channelopathy in pulmonary arterial hypertension.
@en
P2093
Alain Borczuk
Barbara Girerd
Danilo Roman-Campos
Eric D Austin
Florent Soubrier
James E Loyd
Kevin S Sampson
Lijiang Ma
Marine Germain
Mélanie Eyries
P2860
P304
P356
10.1056/NEJMOA1211097
P407
P577
2013-07-01T00:00:00Z